Clinical trial
Efficacy and Safety of Haemocomplettan® P in Patients Experiencing Microvascular Bleeding While Undergoing Elective Complex Cardiac Surgery
NCT01124981 is registered in ClinicalTrials.gov with Isala as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Haemocomplettan® P in Patients Experiencing Microvascular Bleeding While Undergoing Elective Complex Cardiac Surgery
- Lead sponsor
- Isala
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 28, 2011
- Completion date
- December 31, 2014
- Enrollment
- 120 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
fibrinogen deficiency in complex cardiac surgery